Joinn Laboratories (China) Co (SHSE:603127) Equity-to-Asset : 0.82 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Joinn Laboratories (China) Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥7,993 Mil. Joinn Laboratories (China) Co's Total Assets for the quarter that ended in Mar. 2024 was ¥9,733 Mil. Therefore, Joinn Laboratories (China) Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.82.

The historical rank and industry rank for Joinn Laboratories (China) Co's Equity-to-Asset or its related term are showing as below:

SHSE:603127' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.35 Med: 0.57 Max: 0.86
Current: 0.82

During the past 12 years, the highest Equity to Asset Ratio of Joinn Laboratories (China) Co was 0.86. The lowest was 0.35. And the median was 0.57.

SHSE:603127's Equity-to-Asset is ranked better than
86.5% of 237 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs SHSE:603127: 0.82

Joinn Laboratories (China) Co Equity-to-Asset Historical Data

The historical data trend for Joinn Laboratories (China) Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co Equity-to-Asset Chart

Joinn Laboratories (China) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.57

0.56

0.84

0.79

0.83

Joinn Laboratories (China) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Equity-to-Asset	Get a 7-Day Free Trial															0.79	0.79	0.81	0.83	0.82

Competitive Comparison of Joinn Laboratories (China) Co's Equity-to-Asset

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Joinn Laboratories (China) Co's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's Equity-to-Asset falls into.

Joinn Laboratories (China) Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Joinn Laboratories (China) Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	8279.316	/	10027.16
	=	0.83

Joinn Laboratories (China) Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	7993.145	/	9733.254
	=	0.82

Joinn Laboratories (China) Co (SHSE:603127) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Joinn Laboratories (China) Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Joinn Laboratories (China) Co (SHSE:603127) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

06127:Hong Kong

Address

A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176

Website

https://www.joinnlabs.com

Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Joinn Laboratories (China) Co (SHSE:603127) Headlines

No Headlines